This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, E. M. Articles by Kinsella, T. J. Search for Related Content PubMed PubMed Citation Articles by Miller, E. M. Articles by Kinsella, T. J.

Radiosensitization by Fluorodeoxyuridine: Effects of Thymidylate Synthase Inhibition and Cell Synchronization¹

Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin 53792

The combination of fluoropyrimidines and radiation has resulted in increased control of colorectal cancer in the clinic, but the basic mechanism of the interaction is not understood clearly. Preliminary work in our laboratory showed that 2-h exposures of HT 29 human colon carcinoma cells to relatively low levels of 5-fluorodeoxyuridine resulted in extended thymidylate synthase inhibition after the drug was removed (up to 30 h after treatment with 0.5 µM 5-fluorodeoxyuridine). The low cytotoxicity associated with this treatment simplified efforts to test the effects of extended thymidylate synthase inhibition on radiosensitivity of HT 29 cells. Although thymidylate synthase was completely inhibited at the end of the 2-h exposure, an increase in the radiosensitivity of the cells was not evident until 16 h after the removal of drug. Flow cytometric analysis showed that cells accumulated in early S phase over time, and the increase in radiation sensitivity of the entire population followed the increase of the proportion of cells in early S, a relatively radiosensitive phase of the cell cycle. This treatment schedule was compared with 24-h continuous exposure, and we found that the same maximum increase in radiosensitivity was achieved by both treatment strategies. However, more cytotoxicity was associated with continuous exposure. This study provides evidence that radiosensitization by 5-fluorodeoxyuridine is in part due to alteration of cell kinetics and redistribution of cells throughout the cycle. This information may be useful in the design of less toxic combined chemo- and radiotherapy treatment strategies by limiting systemic exposure to fluoropyrimidines.

¹ Research supported by NIH Research Service Awards CA52686 and CA50595.

² Recipient of NIH Training Grant 5T32CA09471. Present address: Division of Toxicology, Massachusetts Institute of Technology, 56-237, Cambridge, MA 02139.

³ To whom requests for reprints should be addressed, at Department of Human Oncology, University of Wisconsin-Madison, 600 Highland Ave. K4/310, Madison, WI 53792.

Received 7/22/91. Accepted 1/15/92.

This article has been cited by other articles:

				F. Buchegger, Y. M. Dupertuis, and F. Perillo-Adamer A Pitfall of Propidium Iodide Staining in Fluorescence-Activated Cell Sorting Cell Cycle Analysis? Cancer Res., June 1, 2007; 67(11): 5576 - 5576. [Full Text] [PDF]

				Y. M. Dupertuis, M. Vazquez, J.-P. Mach, N. De Tribolet, C. Pichard, D. O. Slosman, and F. Buchegger Fluorodeoxyuridine Improves Imaging of Human Glioblastoma Xenografts with Radiolabeled Iododeoxyuridine Cancer Res., November 1, 2001; 61(21): 7971 - 7977. [Abstract] [Full Text] [PDF]

				H.-S. Hwang, T. W. Davis, J. A. Houghton, and T. J. Kinsella Radiosensitivity of Thymidylate Synthase-deficient Human Tumor Cells Is Affected by Progression through the G1 Restriction Point into S-Phase: Implications for Fluoropyrimidine Radiosensitization Cancer Res., January 1, 2000; 60(1): 92 - 100. [Abstract] [Full Text]

				S. E. Berry, C. Garces, H.-S. Hwang, K. Kunugi, M. Meyers, T. W. Davis, D. A. Boothman, and T. J. Kinsella The Mismatch Repair Protein, hMLH1, Mediates 5-Substituted Halogenated Thymidine Analogue Cytotoxicity, DNA Incorporation, and Radiosensitization in Human Colon Cancer Cells Cancer Res., April 1, 1999; 59(8): 1840 - 1845. [Abstract] [Full Text] [PDF]